The study assesses interim analyses in randomized controlled trials for testing new anticancer drugs, focusing on early terminations due to positive results, despite concerns about accuracy and impact.
Is it better for industry or for patients to end an early oncology trial? (5)
author: Andreas Tjandra, drg | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Serial posts:
- Hi-Tec implant restoration in the mandibular first molar region (7)
- Hi-Tec implant restoration in the mandibular first molar region (8)
- Hi-Tec implant restoration in the mandibular first molar region (9)
- Hi-Tec implant restoration in the mandibular first molar region (10)
- Is it better for industry or for patients to end an early oncology trial? (3)
- Is it better for industry or for patients to end an early oncology trial? (4)
- Is it better for industry or for patients to end an early oncology trial? (5)